Position Statement - Monday 4 February, 2008 & Wednesday 2 April, 2008
In connection with the publication in The Lancet entitled ”Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration” and the presentation at CROI 2008 of the poster “Recent Use of Abacavir and Didanosine, but not of Thymidine Analogues, Is Associated with Risk of Myocardial Infarction”(poster No. 957c) the D:A:D steering committee has released a position statement.
Position statement 64 KB
To see the poster please follow this link
Position Statement - Wednesday 19 November, 2003
Position Statement on Combination Antiretroviral Therapy and the Risk of Myocardial Infarction.
Position Statement(33 KB)
In case you would like additional information, please send an e-mail to Dr. Jens D. Lundgren.
Updated: 02 Apr 2008